1. Home
  2. ACTU vs TEAF Comparison

ACTU vs TEAF Comparison

Compare ACTU & TEAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACTU
  • TEAF
  • Stock Information
  • Founded
  • ACTU 2015
  • TEAF 2017
  • Country
  • ACTU United States
  • TEAF United States
  • Employees
  • ACTU N/A
  • TEAF N/A
  • Industry
  • ACTU
  • TEAF Trusts Except Educational Religious and Charitable
  • Sector
  • ACTU
  • TEAF Finance
  • Exchange
  • ACTU NYSE
  • TEAF Nasdaq
  • Market Cap
  • ACTU 135.0M
  • TEAF 155.4M
  • IPO Year
  • ACTU 2024
  • TEAF N/A
  • Fundamental
  • Price
  • ACTU $11.90
  • TEAF $11.74
  • Analyst Decision
  • ACTU Strong Buy
  • TEAF
  • Analyst Count
  • ACTU 1
  • TEAF 0
  • Target Price
  • ACTU $20.00
  • TEAF N/A
  • AVG Volume (30 Days)
  • ACTU 68.4K
  • TEAF 56.1K
  • Earning Date
  • ACTU 05-15-2025
  • TEAF 01-01-0001
  • Dividend Yield
  • ACTU N/A
  • TEAF 9.20%
  • EPS Growth
  • ACTU N/A
  • TEAF N/A
  • EPS
  • ACTU N/A
  • TEAF N/A
  • Revenue
  • ACTU N/A
  • TEAF N/A
  • Revenue This Year
  • ACTU N/A
  • TEAF N/A
  • Revenue Next Year
  • ACTU N/A
  • TEAF N/A
  • P/E Ratio
  • ACTU N/A
  • TEAF N/A
  • Revenue Growth
  • ACTU N/A
  • TEAF N/A
  • 52 Week Low
  • ACTU $5.51
  • TEAF $11.11
  • 52 Week High
  • ACTU $11.99
  • TEAF $13.30
  • Technical
  • Relative Strength Index (RSI)
  • ACTU N/A
  • TEAF 61.78
  • Support Level
  • ACTU N/A
  • TEAF $11.63
  • Resistance Level
  • ACTU N/A
  • TEAF $11.81
  • Average True Range (ATR)
  • ACTU 0.00
  • TEAF 0.13
  • MACD
  • ACTU 0.00
  • TEAF 0.01
  • Stochastic Oscillator
  • ACTU 0.00
  • TEAF 83.33

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

About TEAF Ecofin Sustainable and Social Impact Term Fund

Tortoise Essential Assets Income Term is a USA-based non-diversified, closed-end management investment company. Its investment objective is to provide common shareholders with a high level of total return with an emphasis on current distributions.

Share on Social Networks: